Neurology Specific Literature Search   
 
[home][thesaurus]
    
Click Here to return To Results

 

Treatment of Early Onset Multiple Sclerosis With Subcutaneous Interferon Beta-1a
Neurol 64:888-890, 778, Pohl,D., et al, 2005
See this aricle in Pubmed

Article Abstract
The authors studied the tolerability of subcutaneous interferon beta-1a (IFN?-1a) in 51 patients with early-onset multiple sclerosis. The most frequent systemic adverse effects were flu-like symptoms in 65%. Laboratory abnormalities included asymptomatic leukopenia (27%) and elevated hepatic transaminases (35%). Treatment with IFN?-1a was safe and well tolerated in the majority of children and adolescents.
 
Related Tags
(click to filter results - removes previous filter)

adverse drug reaction
children
flu-like illness
interferon
interferon beta 1-a
leukopenia
liver function enzymes
multiple sclerosis
multiple sclerosis,children
multiple sclerosis,early onset
multiple sclerosis,treatment of
treatment of neurologic disorder

Click Here to return To Results